PMC:7394275 / 4186-4334 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T72","span":{"begin":48,"end":58},"obj":"CHEBI:67079;CHEBI:67079"},{"id":"T79560","span":{"begin":48,"end":58},"obj":"CHEBI:67079;CHEBI:67079"}],"text":" that 2.8% (31/1099) patients were treated with antifungal medicine, including 1.9% (18/926) non-severe patients and 7.5% (13/173) severe patients, "}

{"project":"LitCovid-PubTator","denotations":[{"id":"172","span":{"begin":21,"end":29},"obj":"Species"},{"id":"173","span":{"begin":104,"end":112},"obj":"Species"},{"id":"174","span":{"begin":138,"end":146},"obj":"Species"}],"attributes":[{"id":"A172","pred":"tao:has_database_id","subj":"172","obj":"Tax:9606"},{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"Tax:9606"},{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" that 2.8% (31/1099) patients were treated with antifungal medicine, including 1.9% (18/926) non-severe patients and 7.5% (13/173) severe patients, "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T22","span":{"begin":85,"end":87},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":" that 2.8% (31/1099) patients were treated with antifungal medicine, including 1.9% (18/926) non-severe patients and 7.5% (13/173) severe patients, "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":48,"end":58},"obj":"Chemical"},{"id":"T7","span":{"begin":59,"end":67},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_35718"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":" that 2.8% (31/1099) patients were treated with antifungal medicine, including 1.9% (18/926) non-severe patients and 7.5% (13/173) severe patients, "}